To derive the inhibition constants Kic, Kiu and Kis, we obtained K’m and V’max, the apparent Km and Vmax of the inhibited enzyme at each inhibitor concentration, and plotted K’m/V’max against the inhibitor concentration [I] and 1/V’max against [I] according to Equations 2 to 4 (below). For evaluating inhibition kinetics, different concentrations of inhibitors were added to the assays. Reaction rates were analyzed by Lineweaver-Burke plots to determine the modes of inhibition. If the addition of inhibitor increases the Km, the mode of inhibition is competitive, meaning that the inhibitor and the substrate both bind to the same active site in a competitive manner. If Vmax decreases as the inhibitor is added, the inhibition is non-competitive, meaning that the inhibitor binds to an alternative regulatory site on the enzyme. If a high concentration of substrates reduces the Vmax, the reaction is said to have substrate self-inhibition, that is, multiple substrate molecules can bind to an enzyme forming an inactive complex. Mixed inhibition is when multiple modes of inhibition (competitive, uncompetitive and substrate) are observed. Click here (Materials and Methods). If you have any questions about these data, would like to use these data for publication, or would like to collaborate, please contact Vincent Chiang Click here (Contacts Page).
Last Updated: April 12, 2015
Competitive inhibition equation
Un-competitive inhibition equation
Substrate self-inhibition equation
Family | Protein | Substrate | Product | Inhibitor | pH | Temp oC | Kic µM | Kiu µM | Kis µM |
---|---|---|---|---|---|---|---|---|---|
PAL | PAL1 | Phe | CiA | CiA | 8.5 | 37 | 13.44 ± 5.51 | ||
Phe | CiA | CA | 8.5 | 37 | 3.33 ± 2.73 | 13.44 ± 0.94 | |||
PAL2 | Phe | CiA | CiA | 8.5 | 37 | 8.72 ± 3.25 | 833.31 ± 2.82 | ||
Phe | CiA | CA | 8.5 | 37 | 5.17 ± 2.02 | 15.81 ± 1.57 | |||
PAL3 | Phe | CiA | CiA | 8.5 | 37 | 3.45 ± 0.64 | 49.42 ± 5.41 | ||
Phe | CiA | CA | 8.5 | 37 | 5.17 ± 2.02 | 15.81 ± 1.57 | |||
PAL4 | Phe | CiA | CiA | 8.5 | 37 | 9.02 ± 2.37 | |||
Phe | CiA | CA | 8.5 | 37 | 16.19 ± 5.23 | 15.67 ± 0.79 | |||
PAL5 | Phe | CiA | CiA | 8.5 | 37 | 5.50 ± 3.76 | |||
Phe | CiA | CA | 8.5 | 37 | 13.27 ± 1.90 | 42.45 ± 1.29 | |||
4CL | 4CL3 | 4A | 4ACoA | CA | 8 | 40 | 9.22 ± 2.68 | ||
4A | 4ACoA | FA | 8 | 40 | 55.05 ± 13.20 | ||||
4A | 4ACoA | 5HFA | 8 | 40 | 39.31 ± 3.95 | ||||
4A | 4ACoA | SA | 8 | 40 | 78.11 ± 15.20 | ||||
4A | 4ACoA | 4CoSA | 8 | 40 | 14.55 ± 0.57 | 53.88 ± 3.29 | |||
4A | 4ACoA | CaSA | 8 | 40 | 190.87 ± 4.20 | 532.10 ± 19.60 | |||
CA | CaCoA | 4A | 8 | 40 | 43.73 ± 1.09 | ||||
CA | CaCoA | FA | 8 | 40 | 59.36 ± 12.50 | ||||
CA | CaCoA | 5HFA | 8 | 40 | 198.18 ± 10.03 | ||||
CA | CaCoA | 4CoSA | 8 | 40 | 8.47 ± 3.18 | 27.81 ± 2.98 | |||
FA | FCoA | 4A | 8 | 40 | 13.12 ± 2.82 | ||||
FA | FCoA | CA | 8 | 40 | 3.15 ± 0.26 | ||||
FA | FCoA | 5HFA | 8 | 40 | 7.63 ± 1.75 | ||||
FA | FCoA | SA | 8 | 40 | 163.72 ± 14.40 | ||||
4CL5 | 4A | 4ACoA | CA | 7 | 41 | 7.06 ± 3.10 | 49.75 ± 7.80 | ||
4A | 4ACoA | FA | 7 | 41 | 335.54 ± 76.10 | 178.21 ± 60.70 | |||
4A | 4ACoA | 5HFA | 7 | 41 | 48.80 ± 14.50 | 37.48 ± 5.94 | |||
4A | 4ACoA | SA | 7 | 41 | 631.72 ± 189.00 | 238.41 ± 44.70 | |||
4A | 4ACoA | 4CoSA | 7 | 41 | 44.31 ± 4.29 | 146.96 ± 2.33 | |||
4A | 4ACoA | CaSA | 7 | 41 | 65.55 ± 0.90 | 646.80 ± 7.40 | |||
CA | CaCoA | 4A | 7 | 41 | 122.70 ± 6.70 | 78.07 ± 10.83 | |||
CA | CaCoA | CA | 7 | 41 | 55.97 ± 6.05 | ||||
CA | CaCoA | FA | 7 | 41 | 518.93 ± 28.80 | 372.06 ± 73.26 | |||
CA | CaCoA | 5HFA | 7 | 41 | 45.36 ± 1.75 | 306.81 ± 40.59 | |||
CA | CaCoA | SA | 7 | 41 | 2841.64 ± 101.25 | 157.21 ± 9.35 | |||
CA | CaCoA | 4CoSA | 7 | 41 | 18.44 ± 8.76 | 70.11 ± 9.87 | |||
FA | FCoA | 4A | 7 | 41 | 27.92 ± 3.70 | ||||
FA | FCoA | CA | 7 | 41 | 18.47 ± 0.50 | 14.98 ± 0.67 | |||
FA | FCoA | 5HFA | 7 | 41 | 185.78 ± 56.60 | 18.71 ± 4.62 | |||
FA | FCoA | SA | 7 | 41 | 384.85 ± 30.70 | 450.83 ± 4.10 | |||
CAld5H | CAld5H1 | FA | 5HFA | CnAld | 5.7 | 37 | 0.40 ± 0.03 | 1.50 ± 0.20 | |
CnAlc | 5HCnAlc | CnAld | 5.7 | 37 | 0.84 ± 0.03 | 1.70 ± 0.30 | |||
CAld5H2 | FA | 5HFA | CnAld | 5.1 | 25 | 0.37 ± 0.07 | 1.00 ± 0.04 | ||
CnAlc | 5HCnAlc | CnAld | 5.1 | 25 | 18.80 ± 3.80 | ||||
AldOMT | AldOMT2 | CA | FA | 5HFA | 7.5 | 30 | 38.62 ± 4.94 | 245.04 ± 31.38 | |
CA | FA | CAld | 7.5 | 30 | 2.08 ± 0.46 | 7.57 ± 1.66 | |||
CA | FA | 5HCnAld | 7.5 | 30 | 0.20 ± 0.03 | 2.70 ± 0.41 | |||
CA | FA | CAlc | 7.5 | 30 | 1.63 ± 0.56 | 12.10 ± 4.20 | |||
CA | FA | 5HCnAlc | 7.5 | 30 | 3.80 ± 0.44 | 23.23 ± 2.66 | |||
CAld | CnAld | CA | 7.5 | 30 | 174.68 ± 21.49 | ||||
CAld | CnAld | 5HFA | 7.5 | 30 | 19.79 ± 2.10 | ||||
CAld | CnAld | CAld | 7.5 | 30 | 14.80 ± 0.92 | ||||
CAld | CnAld | 5HCnAld | 7.5 | 30 | 0.55 ± 0.17 | 1.45 ± 0.31 | |||
CAld | CnAld | 5HCnAlc | 7.5 | 30 | 0.80 ± 0.12 | ||||
5HCnAld | SAld | CAld | 7.5 | 30 | 0.29 ± 0.04 | ||||
5HCnAld | SAld | 5HCnAld | 7.5 | 30 | 1.81 ± 0.14 | ||||
5HCnAld | SAld | CAlc | 7.5 | 30 | 2.50 ± 0.60 | 14.37 ± 1.86 | |||
5HCnAld | SAld | 5HCnAlc | 7.5 | 30 | 1.55 ± 0.46 | ||||
CAlc | CnAlc | CAld | 7.5 | 30 | 5.65 ± 0.92 | 0.73 ± 0.06 | |||
CAlc | CnAlc | 5HCnAld | 7.5 | 30 | 0.13 ± 0.01 | 0.54 ± 0.05 | |||
CAlc | CnAlc | CAlc | 7.5 | 30 | 26.60 ± 1.43 | ||||
CAlc | CnAlc | 5HCnAlc | 7.5 | 30 | 3.14 ± 0.68 | ||||
5HCnAlc | SAlc | 5HCnAlc | 7.5 | 30 | 2.28 ± 0.21 | ||||
CAD | CAD1 | CnAld | CnAlc | SAld | 6.1 | 24 | 0.32 ± 0.19 | 3.02 ± 1.12 | |
SAld | SAlc | CnAld | 6.1 | 24 | 0.42 ± 0.39 | 1.92 ± 0.09 |